Preventing metabolic-associated fatty liver disease with fermented cordyceps preparation: an electronic medical record based study
These findings highlight the potential of FCP in MAFLD prevention and offer insight into its safety profile, suggesting avenues for further clinical validation and drug repurposing efforts.
Authors
- Jie Bai (ORCID: https://orcid.org/0000-0002-7993-6797)
- Zijian Tian (ORCID: https://orcid.org/0000-0002-2182-5381)
- Peng Wu (ORCID: https://orcid.org/0000-0001-8109-5694)
- Shaoyun Li (ORCID: https://orcid.org/0000-0002-6019-5730)
- Kaixin Zhou (ORCID: https://orcid.org/0000-0002-4751-7248)
- Runyu Jing (ORCID: https://orcid.org/0000-0003-3375-1014)
- Rong Huang (ORCID: https://orcid.org/0000-0002-0836-2845)
- Xiaozhou Zhou (ORCID: https://orcid.org/0000-0002-4758-0060)
- Jian Shao (ORCID: https://orcid.org/0000-0002-7842-7616)
- Ying Pan
- Ziqing Liu
Institutions
- Jiangsu University (CN)
- Chinese Academy of Sciences (CN)
- Nankai University (CN)
- Jinan Central Hospital (CN)
- First People's Hospital of Kunshan (CN)
- Institute of Biophysics (CN)
- Shandong First Medical University (CN)
- University of Chinese Academy of Sciences (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-05-14
- DOI
- https://doi.org/10.3389/fmed.2025.1576029
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Technology Program of Suzhou